CEREBYX

This brand name is authorized in United States. It is also authorized in Canada.

Active ingredients

The drug CEREBYX contains one active pharmaceutical ingredient (API):

1	Fosphenytoin UNII 7VLR55452Z - FOSPHENYTOIN SODIUM
	Fosphenytoin is a water-soluble phosphate ester prodrug of phenytoin, a hydantoin derivative with anticonvulsant activity. Fosphenytoin is hydrolyzed to phenytoin by phosphatases. Phenytoin exerts its effect mainly by promoting sodium efflux and stabilizes neuronal membranes in the motor cortex. This leads to a suppression of excessive neuronal firing and limits the spread of seizure activity.

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CEREBYX Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AB05	Fosphenytoin	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AB Hydantoin derivatives
Discover more medicines within N03AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02230988
US	FDA, National Drug Code	0069-5471, 0069-5474, 0069-6001